MDxHealth
MDxHealth Files for IPO of American Depository Shares
The company, headquartered in Belgium and the US, hasn't yet made public the number of ADSs it plans to offer, or the timing and price for the offering.
MDxHealth H1 2021 Revenues Up 9 Percent As Testing Volumes Rebound
The firm saw volume growth of 4 percent for its ConfirmMDx prostate cancer test and 9 percent for its SelectMDx test.
Palmetto Releases Draft LCD for Prostate Cancer Risk Stratification Tests
Under the local coverage determination, tests to help identify patients who may benefit from a prostate biopsy would be covered under certain conditions.
MDxHealth 2020 Revenues Up 57 Percent
Billable test volume for the company's ConfirmMDx and SelectMDx prostate cancer test fell year over year, but rose sequentially from the third quarter.
Oppenheimer Initiates Coverage of MDxHealth at Outperform
The investment bank cited its expectation for a positive coverage decision from Medicare for the company's SelectMDx prostate cancer test, among other reasons.
Oct 21, 2020
MDxHealth Q3 2020 Revenues Drop 6 Percent
Feb 26, 2020
MDxHealth 2019 Revenues Fall 58 Percent
Aug 29, 2019
MDxHealth H1 2019 Revenues Fall 37 Percent
Apr 24, 2019
MDxHealth Q1 Revenues Drop 51 Percent
Aug 30, 2018